Arash Memarnejadian

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Oxidative Stress

Top Venues

Expert review of gastroenterology & hepatology

Advanced pharmaceutical bulletin

Drug development and industrial pharmacy

This page only lists publications with an associated author ORCID identifier.

Publications

Alireza Beheshti-Maal, Atena Tamimi, Shahrokh Iravani, Arash Memarnejadian, Majid Sorouri, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali, Nikoo Hossein Khannazer, Abdolhossein Shahverdi
PSC associated inflammatory bowel disease: a distinct entity. Expert review of gastroenterology & hepatology 16 (2) (2022)
Mahsa Ghasemzad, Seyed Mohammad Reza Hashemian, Arash Memarnejadian, Iman Akbarzadeh, Nikoo Hossein-Khannazer, Massoud Vosough
The nano-based theranostics for respiratory complications of COVID-19. Drug development and industrial pharmacy (2021)
Courtney E Meilleur, Arash Memarnejadian, Adil N Shivji, Jenna M Benoit, Stephen W Tuffs, Tina S Mele, Bhagirath Singh, Jimmy D Dikeakos, David J Topham, Hong-Hua Mu, Jack R Bennink, John K McCormick, S M Mansour Haeryfar
Discordant rearrangement of primary and anamnestic CD8+ T cell responses to influenza A viral epitopes upon exposure to bacterial superantigens: Implications for prophylactic vaccination, heterosubtypic immunity and superinfections. PLoS pathogens 16 (5) (2020)
Hadi Bayat, Fatemeh Naderi, Amjad Hayat Khan, Arash Memarnejadian, Azam Rahimpour
The Impact of CRISPR-Cas System on Antiviral Therapy. Advanced pharmaceutical bulletin 8 (4) (2018)